[Federal Register Volume 83, Number 49 (Tuesday, March 13, 2018)]
[Notices]
[Pages 10853-10855]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-05000]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-2018-1091; Docket No. CDC-2018-0022]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled ''Using Qualitative Methods to
Understand Issues in HIV Prevention, Care and Treatment in the United
States.'' CDC's goal for this generic information collection mechanism
is to conduct qualitative studies to quickly identify barriers and
facilitators to HIV prevention, care and treatment in specific regions
with high HIV burden in the US.
DATES: CDC must receive written comments on or before May 14, 2018.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2018-
0022 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal
eRulemaking portal (regulations.gov) or by U.S. mail to the address
listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Leroy A. Richardson, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road, NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-
3520), Federal agencies must obtain approval from the Office of
Management and Budget (OMB) for each collection of information they
conduct or sponsor. In addition, the PRA also requires Federal agencies
to provide a 60-day notice in the Federal Register concerning each
proposed collection of information, including each new proposed
collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Using Qualitative Methods to Understand Issues in HIV Prevention,
Care and Treatment in the United States (OMB Control Number 0920-1091;
expires 12/31/2018)--Extension--National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention, Centers for Disease Control and
Prevention (CDC).
[[Page 10854]]
Background and Brief Description
The CDC's National Center on HIV/AIDS, Viral Hepatitis, STD and TB
Prevention (NCHHSTP), Division of HIV/AIDS Prevention (DHAP) seeks a
three-year extension to conduct qualitative studies to quickly identify
barriers and facilitators to HIV prevention, care and treatment in
specific regions with high HIV burden in the US. Proposed activities
remain consistent with the national HIV prevention goals, the CDC
Division of HIV/AIDS Prevention (DHAP) Strategic Plan, and DHAP's High-
impact HIV Prevention approach.
The purposes for each data collection study supported under this
umbrella generic information collection plan will be to understand
specific barriers and facilitators to local HIV prevention, care and
treatment in the United States and territories. For example, each study
will seek to identify ways to improve programmatic activities along the
continuum of HIV prevention, treatment and care for different
populations residing in different geographic settings with greatest
burden of HIV.
The target populations for the studies include, but are not limited
to: (1) Persons living with HIV who are in treatment; (2) persons
living with HIV who are out of treatment and who may or may not be
seeking treatment at healthcare facilities; (3) persons at high risk
for HIV acquisition (HIV negative) and HIV transmission (HIV positive);
(4) persons from groups at high risk for HIV including gay, bisexual
and other MSM, transgender persons, and injection and non-injection
drug users; (5) persons from racial and ethnic minorities; and (6)
healthcare providers or other professionals who provide HIV prevention,
care and treatment services. Other populations may include individuals
who provide non-HIV services or otherwise interact with persons living
with HIV or persons at risk for HIV acquisition.
Studies will only provide local contextual information about the
barriers and facilitators to HIV prevention, care, and treatment
experienced by specific communities at risk for acquiring HIV
infection, by HIV-positive persons across the HIV care continuum, and
by organizations or individuals providing HIV prevention, care,
treatment, and related support services.
Data collection methods used in any of the specific studies
primarily will consist of rapid qualitative assessment methodologies,
such as semi-structured and in-depth qualitative interviews, focus
groups; direct observations; document reviews; and short structured
surveys. Data will be analyzed using well-established qualitative
analysis methods, such as coding interviews for themes about barriers
and successes to HIV prevention, care, and treatment. Structured
response surveys will be analyzed using descriptive statistics and
other appropriate statistical methods.
CDC will use the results from each specific data collection study
to help identify ways to improve local programmatic activities for
specific communities along the continuum of HIV prevention, treatment
and care for populations and areas with the greatest HIV burden. CDC
will communicate study outcomes to local stakeholders and organizations
in positions to consider and implement site-specific improvements in
HIV prevention, care, and treatment for each of the study sites
examined. For stakeholders, organizations, or agencies outside the
local affected communities, all communications will include clear
discussion of the limitations of the region-specific, qualitative
methods and the non-generalizability of the study outcomes.
For a given year, each separate data collection will range from 30
(minimum) to 200 (maximum) respondents, based on the nature and scope
of the research purposes. For example, if there are three data
collections, the maximum combined number of expected respondents is
600. In a given year, CDC anticipates the need to screen 1,600 persons
to identify 800 eligible persons, of which 600 persons will agree to
participate.
CDC anticipates that screener forms will take 5 minutes to complete
each, contact information forms will take 1 minute to complete each,
and consent forms will take 5 minutes to complete each. CDC anticipates
study eligibility for 50 percent of the targeted populations screened.
Of eligible persons, 75% will agree to participate.
Brief structured surveys will take 15 minutes to complete. In-depth
interviews or focus groups with respondents are expected to take 60
minutes (1 hour) to complete. In-depth interviews or focus groups with
healthcare providers are expected to take 45 minutes to complete.
The total annual response burden, based on an average of 600 study
respondents per year (assuming three large data collections involving
200 participants each), is 918 hours.
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
General Public--Adults........ Study Screener.. 1,600 1 5/60 133
General Public--Adults........ Contact 600 1 1/60 10
Information
Form.
General Public--Adults........ Consent Form.... 600 1 5/60 50
General Public--Adults........ Demographic 500 1 15/60 125
Survey.
General Public--Adults........ Interview Guide. 500 1 1 500
General Public--Adults........ Provider 100 1 15/60 25
Demographic
Survey.
General Public--Adults........ Provider 100 1 45/60 75
Interview Guide.
---------------
Total..................... ................ .............. .............. .............. 918
----------------------------------------------------------------------------------------------------------------
[[Page 10855]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-05000 Filed 3-12-18; 8:45 am]
BILLING CODE 4163-18-P